Microwave-accelerated synthesis of p1′-extended HIV-1 protease inhibitors encompassing a tertiary alcohol in the transition-state mimicking scaffold

被引：43

作者：

Ekegren, JK

Ginman, N

Johansson, Å

Wallberg, H

Larhed, M

Samuelsson, B

Unge, T

Hallberg, A

机构：

[1] Uppsala Univ, Dept Med Chem, BMC, SE-75123 Uppsala, Sweden

[2] Uppsala Univ, Dept Cell & Mol Biol, BMC, SE-75124 Uppsala, Sweden

[3] Medivir AB, SE-14144 Huddinge, Sweden

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2006年 / 49卷 / 05期

关键词：

D O I：

10.1021/jm051239z

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Two series of P1'-extended HIV-1 protease inhibitors comprising a tertiary alcohol in the transition-state mimic exhibiting K-i values ranging from 2.1 to 93 nM have been synthesized. Microwave-accelerated palladium-catalyzed cross-couplings were utilized to rapidly optimize the P1' side chain. High cellular antiviral potencies were encountered when the P1' benzyl group was elongated with a 3- or 4-pyridyl substituent (EC50 = 0.18-0.22 mu M). X-ray crystallographic data were obtained for three inhibitors cocrystallized with the enzyme.

引用

页码：1828 / 1832

页数：5

共 39 条

[31] BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents [J].

Robinson, BS ;

Riccardi, KA ;

Gong, YF ;

Guo, Q ;

Stock, DA ;

Blair, WS ;

Terry, BJ ;

Deminie, CA ;

Djang, F ;

Colonno, RJ ;

Lin, PF .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) :2093-2099

[32] HIV protease inhibition:: Limited recent progress and advances in understanding current pitfalls [J].

Rodríguez-Barrios, F ;

Gago, F .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) :991-1007

[33]

SAVIN VI, 1992, ZH ORG KHIM+, V28, P43

[34]

Sonogashira K., 2002, Handbook of Organopalladium Chemistry for Organic Synthesis, P493

[35] Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors [J].

Thaisrivongs, S ;

Romero, DL ;

Tommasi, RA ;

Janakiraman, MN ;

Strohbach, JW ;

Turner, SR ;

Biles, C ;

Morge, RR ;

Johnson, PD ;

Aristoff, PA ;

Tomich, PK ;

Lynn, JC ;

Horng, MM ;

Chong, KT ;

Hinshaw, RR ;

Howe, WJ ;

Finzel, BC ;

Watenpaugh, KD .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (23) :4630-4642

[36] Tipranavir (PNU-140690): A potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class [J].

Turner, SR ;

Strohbach, JW ;

Tommasi, RA ;

Aristoff, PA ;

Johnson, PD ;

Skulnick, HI ;

Dolak, LA ;

Seest, EP ;

Tomich, PK ;

Bohanan, MJ ;

Horng, MM ;

Lynn, JC ;

Chong, KT ;

Hinshaw, RR ;

Watenpaugh, KD ;

Janakiraman, MN ;

Thaisrivongs, S .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3467-3476

[37] L-735,524 - AN ORALLY BIOAVAILABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR [J].

VACCA, JP ;

DORSEY, BD ;

SCHLEIF, WA ;

LEVIN, RB ;

MCDANIEL, SL ;

DARKE, PL ;

ZUGAY, J ;

QUINTERO, JC ;

BLAHY, OM ;

ROTH, E ;

SARDANA, VV ;

SCHLABACH, AJ ;

GRAHAM, PI ;

CONDRA, JH ;

GOTLIB, L ;

HOLLOWAY, MK ;

LIN, J ;

CHEN, IW ;

VASTAG, K ;

OSTOVIC, D ;

ANDERSON, PS ;

EMINI, EA ;

HUFF, JR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4096-4100

[38] High-speed synthesis of potent C2-symmetric HIV-1 protease inhibitors by in-situ aminocarbonylations [J].

Wannberg, J ;

Kaiser, NFK ;

Vrang, L ;

Samuelsson, B ;

Larhed, M ;

Hallberg, A .

JOURNAL OF COMBINATORIAL CHEMISTRY, 2005, 7 (04) :611-617

[39] The effect of increasing α1-acid glycoprotein concentration on the antiviral efficacy of human immunodeficiency virus protease inhibitors [J].

Zhang, XQ ;

Schooley, RT ;

Gerber, JG .

JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) :1833-1837

← 1 2 3 4 →